{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:29:19Z","timestamp":1793089759633,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KFO262"],"award-info":[{"award-number":["KFO262"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FOR 2127"],"award-info":[{"award-number":["FOR 2127"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.prp.2019.152752","type":"journal-article","created":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T11:43:28Z","timestamp":1574077408000},"page":"152752","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Characterization of glycolysis-related gene expression in malignant melanoma"],"prefix":"10.1016","volume":"216","author":[{"given":"Andreas","family":"Koch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Vanessa","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Berneburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Bosserhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Hellerbrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2019.152752_bib0005","first-page":"120","article-title":"Epidemiology of skin cancer","volume":"810","author":"Leiter","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"issue":"10","key":"10.1016\/j.prp.2019.152752_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047054","article-title":"The prognostic value of BRAF mutation in colorectal cancer and melanoma: a systematic review and meta-analysis","volume":"7","author":"Safaee Ardekani","year":"2012","journal-title":"PLoS One"},{"issue":"26","key":"10.1016\/j.prp.2019.152752_bib0015","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.prp.2019.152752_bib0020","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.prp.2019.152752_bib0025","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1085\/jgp.8.6.519","article-title":"The metabolism of tumors in the body","volume":"8","author":"Warburg","year":"1927","journal-title":"J. Gen. Physiol."},{"issue":"49","key":"10.1016\/j.prp.2019.152752_bib0030","doi-asserted-by":"crossref","first-page":"42626","DOI":"10.1074\/jbc.M111.282046","article-title":"Comparative metabolic flux profiling of melanoma cell lines: beyond the Warburg effect","volume":"286","author":"Scott","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"32","key":"10.1016\/j.prp.2019.152752_bib0035","doi-asserted-by":"crossref","first-page":"32748","DOI":"10.18632\/oncotarget.4977","article-title":"Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells","volume":"6","author":"Koch","year":"2015","journal-title":"Oncotarget."},{"issue":"Suppl. 3","key":"10.1016\/j.prp.2019.152752_bib0040","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12863-016-0459-1","article-title":"Effect of lentivirus-mediated shRNA inactivation of HK1, HK2, and HK3 genes in colorectal cancer and melanoma cells","volume":"17","author":"Kudryavtseva","year":"2016","journal-title":"BMC Genet."},{"issue":"18","key":"10.1016\/j.prp.2019.152752_bib0045","doi-asserted-by":"crossref","first-page":"8927","DOI":"10.1158\/0008-5472.CAN-06-1501","article-title":"Cancer\u2019s molecular sweet tooth and the Warburg effect","volume":"66","author":"Kim","year":"2006","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.prp.2019.152752_bib0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2217\/fon.09.145","article-title":"Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation","volume":"6","author":"Kennedy","year":"2010","journal-title":"Future Oncol."},{"key":"10.1016\/j.prp.2019.152752_bib0055","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1476-4598-11-76","article-title":"Importance of glycolysis and oxidative phosphorylation in advanced melanoma","volume":"11","author":"Ho","year":"2012","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.prp.2019.152752_bib0060","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrc2468","article-title":"Denko NC. Hypoxia, HIF1 and glucose metabolism in the solid tumour","volume":"8","year":"2008","journal-title":"Nat. Rev. Cancer"},{"issue":"17","key":"10.1016\/j.prp.2019.152752_bib0065","doi-asserted-by":"crossref","first-page":"23141","DOI":"10.18632\/oncotarget.8153","article-title":"The altered glucose metabolism in tumor and a tumor acidic microenvironment associated with extracellular matrix metalloproteinase inducer and monocarboxylate transporters","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget."},{"issue":"2","key":"10.1016\/j.prp.2019.152752_bib0070","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ceb.2007.02.003","article-title":"Hypoxia signalling controls metabolic demand","volume":"19","author":"Brahimi-Horn","year":"2007","journal-title":"Curr. Opin. Cell Biol."},{"issue":"7","key":"10.1016\/j.prp.2019.152752_bib0075","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1158\/0008-5472.CAN-06-3312","article-title":"Mutant V600E BRAF increases hypoxia inducible factor-1alpha expression in melanoma","volume":"67","author":"Kumar","year":"2007","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.prp.2019.152752_bib0080","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0002-9440(10)65730-6","article-title":"Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma","volume":"153","author":"Hsu","year":"1998","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2019.152752_bib0085","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/sj.onc.1201566","article-title":"ATF2 confers radiation resistance to human melanoma cells","volume":"16","author":"Ronai","year":"1998","journal-title":"Oncogene."},{"issue":"10","key":"10.1016\/j.prp.2019.152752_bib0090","first-page":"3602","article-title":"Specific immunoreactivity of hybridoma-secreted monoclonal anti-melanoma antibodies to cultured cells and freshly derived human cells","volume":"40","author":"Herlyn","year":"1980","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2019.152752_bib0095","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1476-4598-8-104","article-title":"Expression and function of hypoxia inducible factor-1 alpha in human melanoma under non-hypoxic conditions","volume":"8","author":"Mills","year":"2009","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.prp.2019.152752_bib0100","first-page":"283","article-title":"Primary melanoma cells of the vertical growth phase: similarities to metastatic cells","volume":"74","author":"Herlyn","year":"1985","journal-title":"J. Natl. Cancer Inst."},{"issue":"12","key":"10.1016\/j.prp.2019.152752_bib0105","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.bcp.2013.09.020","article-title":"A novel binuclear palladacycle complex inhibits melanoma growth in vitro and in vivo through apoptosis and autophagy","volume":"86","author":"Aliwaini","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.prp.2019.152752_bib0110","first-page":"188","article-title":"Shifts in cadherin profiles between human normal melanocytes and melanomas","volume":"1","author":"Hsu","year":"1996","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"issue":"10","key":"10.1016\/j.prp.2019.152752_bib0115","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/eji.1830111015","article-title":"Surface antigens of human melanoma cells defined by monoclonal antibodies. I. Biochemical characterization of two antigens found on cell lines and fresh tumors of diverse tissue origin","volume":"11","author":"Johnson","year":"1981","journal-title":"Eur. J. Immunol."},{"issue":"8","key":"10.1016\/j.prp.2019.152752_bib0120","first-page":"2296","article-title":"In vitro properties of human melanoma cells metastatic in nude mice","volume":"50","author":"Herlyn","year":"1990","journal-title":"Cancer Res."},{"issue":"Suppl. 2","key":"10.1016\/j.prp.2019.152752_bib0125","first-page":"S35","article-title":"Melanoma cell lines from different stages of progression and their biological and molecular analyses","volume":"7","author":"Satyamoorthy","year":"1997","journal-title":"Melanoma Res."},{"issue":"1","key":"10.1016\/j.prp.2019.152752_bib0130","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/carcin\/bgi201","article-title":"Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma","volume":"27","author":"Hellerbrand","year":"2006","journal-title":"Carcinogenesis."},{"issue":"11","key":"10.1016\/j.prp.2019.152752_bib0135","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1080\/15384101.2016.1175258","article-title":"The metabolic microenvironment of melanomas: prognostic value of MCT1 and MCT4","volume":"15","author":"Pinheiro","year":"2016","journal-title":"Cell Cycle"},{"issue":"5","key":"10.1016\/j.prp.2019.152752_bib0140","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-associated lactic acid production blunts tumor immunosurveillance by t and NK cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.prp.2019.152752_bib0145","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1215\/15228517-2008-106","article-title":"Lactate promotes glioma migration by TGF-beta2-dependent regulation of matrix metalloproteinase-2","volume":"11","author":"Baumann","year":"2009","journal-title":"Neuro Oncol."},{"issue":"34","key":"10.1016\/j.prp.2019.152752_bib0150","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1038\/sj.onc.1209597","article-title":"Glycolysis inhibition for anticancer treatment","volume":"25","author":"Pelicano","year":"2006","journal-title":"Oncogene."},{"issue":"4","key":"10.1016\/j.prp.2019.152752_bib0155","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1023\/A:1022494613613","article-title":"Aberrant glycolytic metabolism of cancer cells: a remarkable coordination of genetic, transcriptional, post-translational, and mutational events that lead to a critical role for type II hexokinase","volume":"29","author":"Mathupala","year":"1997","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.prp.2019.152752_bib0160","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fphar.2011.00049","article-title":"Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review","volume":"2","author":"Porporato","year":"2011","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.prp.2019.152752_bib0165","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00424-003-1067-2","article-title":"The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond","volume":"447","author":"Halestrap","year":"2004","journal-title":"Pflugers Arch."},{"issue":"14","key":"10.1016\/j.prp.2019.152752_bib0170","doi-asserted-by":"crossref","first-page":"9030","DOI":"10.1074\/jbc.M511397200","article-title":"The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism","volume":"281","author":"Ullah","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.prp.2019.152752_bib0175","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/sj.onc.1210704","article-title":"BRAF(E600) in benign and malignant human tumours","volume":"27","author":"Michaloglou","year":"2008","journal-title":"Oncogene."},{"issue":"6892","key":"10.1016\/j.prp.2019.152752_bib0180","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature."},{"issue":"4","key":"10.1016\/j.prp.2019.152752_bib0185","doi-asserted-by":"crossref","first-page":"584","DOI":"10.18632\/oncotarget.965","article-title":"Dysfunctional oxidative phosphorylation makes malignant melanoma cells addicted to glycolysis driven by the (V600E)BRAF oncogene","volume":"4","author":"Hall","year":"2013","journal-title":"Oncotarget."},{"issue":"1","key":"10.1016\/j.prp.2019.152752_bib0190","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1084\/jem.20082044","article-title":"Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma","volume":"206","author":"Massoumi","year":"2009","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.prp.2019.152752_bib0195","first-page":"268","article-title":"Biological role and prognostic significance of genetic alterations in human malignant melanomas","volume":"59","author":"Vizkeleti","year":"2015","journal-title":"Magy. Onkol."},{"key":"10.1016\/j.prp.2019.152752_bib0200","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1186\/1471-2407-14-630","article-title":"Macrophage migration inhibitory factor engages PI3K\/Akt signalling and is a prognostic factor in metastatic melanoma","volume":"14","author":"Oliveira","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2019.152752_bib0205","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.humpath.2015.12.003","article-title":"BRAF inhibitor therapy-associated melanocytic lesions lack the BRAF V600E mutation and show increased levels of cyclin D1 expression","volume":"50","author":"Mudaliar","year":"2016","journal-title":"Hum. Pathol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033819319831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033819319831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:56:15Z","timestamp":1778547375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033819319831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0344033819319831"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2019.152752","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of glycolysis-related gene expression in malignant melanoma","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2019.152752","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152752"}}